Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106836164 | 10683616 | 4 | F | 20140519 | 20160921 | 20141230 | 20160927 | EXP | PHHY2014JP167517 | NOVARTIS | 62.39 | YR | M | Y | 61.00000 | KG | 20160927 | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106836164 | 10683616 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, BID | Y | 22068 | 300 | MG | CAPSULE | BID | |||||
| 106836164 | 10683616 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 300 MG, BID | Y | 22068 | 300 | MG | CAPSULE | BID | |||||
| 106836164 | 10683616 | 3 | C | ADALAT | NIFEDIPINE | 1 | Oral | 20 MG, BID | Y | 0 | 20 | MG | TABLET | BID | |||||
| 106836164 | 10683616 | 4 | C | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | 4 MG, UNK | 0 | 4 | MG | TABLET | |||||||
| 106836164 | 10683616 | 5 | C | CANDESARTAN | CANDESARTAN | 1 | Unknown | 8 MG, UNK | U | 0 | 8 | MG | |||||||
| 106836164 | 10683616 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 106836164 | 10683616 | 7 | C | RIVAROXABAN | RIVAROXABAN | 1 | Unknown | 15 MG, UNK | U | 0 | 15 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106836164 | 10683616 | 1 | Chronic myeloid leukaemia |
| 106836164 | 10683616 | 3 | Hypertension |
| 106836164 | 10683616 | 4 | Hypertension |
| 106836164 | 10683616 | 5 | Product used for unknown indication |
| 106836164 | 10683616 | 6 | Product used for unknown indication |
| 106836164 | 10683616 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106836164 | 10683616 | OT |
| 106836164 | 10683616 | LT |
| 106836164 | 10683616 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106836164 | 10683616 | Acute coronary syndrome | |
| 106836164 | 10683616 | Angina pectoris | |
| 106836164 | 10683616 | Bundle branch block left | |
| 106836164 | 10683616 | Bundle branch block right | |
| 106836164 | 10683616 | Chest discomfort | |
| 106836164 | 10683616 | Chest pain | |
| 106836164 | 10683616 | Coronary artery restenosis | |
| 106836164 | 10683616 | Coronary artery stenosis | |
| 106836164 | 10683616 | Electrocardiogram ST segment depression | |
| 106836164 | 10683616 | Fatigue | |
| 106836164 | 10683616 | Myocardial infarction | |
| 106836164 | 10683616 | Palpitations |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106836164 | 10683616 | 1 | 20120827 | 201406 | 0 | |
| 106836164 | 10683616 | 2 | 201406 | 20150205 | 0 |